Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mizuho Financial Group Inc. Sponosred ADR (Japan) (MFG) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Mizuho Financial Group Inc. Sponosred ADR (Japan)Trade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Mizuho Financial Group Inc. Sponosred ADR (Japan) vs Zimmer Biomet Holdings Inc — how do they compare? Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.41 (market cap $132.18B), while Zimmer Biomet Holdings Inc trades at $88.9 (market cap $16.88B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 7.8× Zimmer Biomet Holdings Inc's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays the higher dividend (1.7%). Which is the better fit depends on your goals — on Pluang, investors hold Mizuho Financial Group Inc. Sponosred ADR (Japan) for 0 Days and Zimmer Biomet Holdings Inc for 89 Days on average.

MFGZBH
Market Cap
$132.18B$16.88B
Volume
3,264,6621,991,354
Sector
FinancialsHealth
52-Week High
$11.45$103.98
52-Week Low
$6.09$79.58
Typical Hold Time
0 Days89 Days
Enterprise Value
$35.48T$23.95B
Dividend Yield
1.7%1.08%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Mizuho Financial Group Inc. Sponosred ADR (Japan)

No Aura AI signal available yet.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $88.91, down 0.86% on the day, with a bearish technical signal from moving averages. The company reported revenue of $8.23B in 2025, with net income of $705.1M, and has beaten EPS estimates for the last three quarters. Recent news highlights a quarterly dividend declaration and leadership promotions aimed at accelerating commercial transformation.

The outlook is mixed: strong fundamentals and consistent earnings beats support growth, but technical indicators and rising debt-to-asset ratios pose risks. Analyst consensus suggests a 16% upside to the $103.11 price target, though nearly half of analysts recommend Hold. Key risks include competitive pressures and execution of the company's strategic initiatives.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MFG
100% Buy0% Sell
Avg holding period · 0 Days
ZBH
100% Buy0% Sell
Avg holding period · 89 Days

Top news

Latest headlines on both assets

About Mizuho Financial Group Inc. Sponosred ADR (Japan)

Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.

Read more on MFG →

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH →